151 related articles for article (PubMed ID: 12663990)
41. Angiotensin-converting enzyme inhibition modulates mitogen-activated protein kinase family expressions in the neonatal rat kidney.
Choi BM; Yoo KH; Bae IS; Oh MH; Hong YS; Lee JW; Kim SK
Pediatr Res; 2005 Jan; 57(1):115-23. PubMed ID: 15531746
[TBL] [Abstract][Full Text] [Related]
42. Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia.
Nakanishi K; Saito Y; Azuma N; Sasajima T
J Vasc Surg; 2013 Jan; 57(1):182-93, 193.e1-10. PubMed ID: 23127979
[TBL] [Abstract][Full Text] [Related]
43. Wall shear modulation of cytokines in early vein grafts.
Jiang Z; Berceli SA; Pfahnl CL; Wu L; Goldman D; Tao M; Kagayama M; Matsukawa A; Ozaki CK
J Vasc Surg; 2004 Aug; 40(2):345-50. PubMed ID: 15297832
[TBL] [Abstract][Full Text] [Related]
44. Role of mitogen-activated protein kinases in pulmonary endothelial cells exposed to cyclic strain.
Kito H; Chen EL; Wang X; Ikeda M; Azuma N; Nakajima N; Gahtan V; Sumpio BE
J Appl Physiol (1985); 2000 Dec; 89(6):2391-400. PubMed ID: 11090594
[TBL] [Abstract][Full Text] [Related]
45. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease.
Cook SA; Sugden PH; Clerk A
J Mol Cell Cardiol; 1999 Aug; 31(8):1429-34. PubMed ID: 10423341
[TBL] [Abstract][Full Text] [Related]
46. Target selectivity of MAPK phosphorothioate antisense ODN on p42/p44, p38 MAPK, and JNK protein expression and its inhibitory effect on VSMC DNA synthesis.
Huang SL; Ding B; Li J; Yi FX; Liu WL; Yu QS; Guo ZG
Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):613-7. PubMed ID: 10678124
[TBL] [Abstract][Full Text] [Related]
47. Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogen-activated protein kinase.
Chen Q; Li W; Quan Z; Sumpio BE
J Vasc Surg; 2003 Mar; 37(3):660-8. PubMed ID: 12618707
[TBL] [Abstract][Full Text] [Related]
48. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
[TBL] [Abstract][Full Text] [Related]
50. A novel promising therapy for vein graft restenosis: overexpressed Nogo-B induces vascular smooth muscle cell apoptosis by activation of the JNK/p38 MAPK signaling pathway.
Zheng H; Xue S; Lian F; Wang YY
Med Hypotheses; 2011 Aug; 77(2):278-81. PubMed ID: 21612877
[TBL] [Abstract][Full Text] [Related]
51. Anti-proliferative and anti-inflammatory effects of topical MAPK inhibition in arterialized vein grafts.
Pintucci G; Saunders PC; Gulkarov I; Sharony R; Kadian-Dodov DL; Bohmann K; Baumann FG; Galloway AC; Mignatti P
FASEB J; 2006 Feb; 20(2):398-400. PubMed ID: 16303874
[TBL] [Abstract][Full Text] [Related]
52. Balloon catheter injury and vein graft morphology and function.
Davies MG; Dalen H; Svendsen E; Hagen PO
Ann Vasc Surg; 1996 Sep; 10(5):429-42. PubMed ID: 8905062
[TBL] [Abstract][Full Text] [Related]
53. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.
Reboul P; Pelletier JP; Tardif G; Benderdour M; Ranger P; Bottaro DP; Martel-Pelletier J
Arthritis Rheum; 2001 Jan; 44(1):73-84. PubMed ID: 11212179
[TBL] [Abstract][Full Text] [Related]
54. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
55. Activation of the p38 and p42/p44 mitogen-activated protein kinase families by the histamine H(1) receptor in DDT(1)MF-2 cells.
Robinson AJ; Dickenson JM
Br J Pharmacol; 2001 Aug; 133(8):1378-86. PubMed ID: 11498525
[TBL] [Abstract][Full Text] [Related]
56. Differential Activation of Mitogen-Activated Protein Kinases, ERK 1/2, p38(MAPK) and JNK p54/p46 During Postnatal Development of Rat Hippocampus.
Costa AP; Lopes MW; Rieger DK; Barbosa SG; Gonçalves FM; Xikota JC; Walz R; Leal RB
Neurochem Res; 2016 May; 41(5):1160-9. PubMed ID: 26700434
[TBL] [Abstract][Full Text] [Related]
57. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
[TBL] [Abstract][Full Text] [Related]
58. Diabetes alters vascular mechanotransduction: pressure-induced regulation of mitogen activated protein kinases in the rat inferior vena cava.
Rice KM; Desai DH; Kakarla SK; Katta A; Preston DL; Wehner P; Blough ER
Cardiovasc Diabetol; 2006 Sep; 5():18. PubMed ID: 16961925
[TBL] [Abstract][Full Text] [Related]
59. The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression.
Silvers AL; Bachelor MA; Bowden GT
Neoplasia; 2003; 5(4):319-29. PubMed ID: 14511403
[TBL] [Abstract][Full Text] [Related]
60. Fucoidan/FGF-2 induces angiogenesis through JNK- and p38-mediated activation of AKT/MMP-2 signalling.
Kim BS; Park JY; Kang HJ; Kim HJ; Lee J
Biochem Biophys Res Commun; 2014 Aug; 450(4):1333-8. PubMed ID: 25003321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
